Dynamics of peripheral lymphocyte subsets in gastric cancer patients underwent laparoscopic D2 gastrectomy

Author:

Tong Yi Xin1,Gao Chun1,Zeng Ci Dian Dan1,Zhu Li1,Zhang Sheng1

Affiliation:

1. Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Abstract

Abstract Background: Postoperative complications and poor short-term outcomes were common among patients with locally advanced gastric cancer. This study aimed to explore the postoperative peripheral lymphocyte subsets dynamics and potential factors associated with decreased postoperative lymphocyte subset counts in patients with gastric cancer after laparoscopic D2 gastrectomy. Methods: The clinicopathological characteristics of the included patients were retrospectively collected. We recorded the data of perioperative peripheral lymphocyte subset counts. We investigate the impact factors associated with decreased postoperative lymphocytes subset counts in univariate and multivariate analysis. Results: In total, 169 patients were included in the final analysis. On postoperative day 7, the median percentage of T cell, B cell, NK cell and memory T cell decrease was -26.1%, -30.8%, -44.8% and -2.3% respectively. The median percentage of naive T cell and regulatory T cell change was 6.0% and 15.0% respectively. Postoperative thymosin alpha 1 (Tα1) treatment was a protective factor for postoperative T cell and B cell decrease (p<0.05). In the multivariate analysis, the independent predictive factors for postoperative T cell decrease were Interleukin-1β level (HR=3.66, p=0.01), operation time (HR=2.98, p=0.02) and Tα1 therapy (HR=0.15, p<0.01) Conclusions: Our findings revealed the dynamics and impact factors for postoperative lymphocyte subsets change in patients with gastric cancer after laparoscopic D2 gastrectomy. We also found that Tα1 treatment was a protective factor for postoperative T and B lymphocyte decrease.

Publisher

Research Square Platform LLC

Reference37 articles.

1. Hallmarks of Cancer: New Dimensions;Hanahan D;Cancer Discov,2022

2. Systemic immunity in cancer;Hiam-Galvez KJ;Nat Rev Cancer,2021

3. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021; CA Cancer J Clin. 2021;71(1):7–33.

4. Gastric cancer;Smyth EC;Lancet,2020

5. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.N;Sakuramoto S;Engl J Med,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3